Johan Thideman is an experienced professional in the pharmaceutical and healthcare consulting sectors, currently serving as the Nordic Business Unit Director for Rare Disease & Neuroscience at Ipsen since May 2019. With a background that includes roles such as Global Commercial Director for oncology products like Non-small Cell Lung Cancer (NSCLC) and Renal Cell Carcinoma (RCC), Johan has demonstrated leadership in global pre-launch and launch preparations. Prior experience includes positions at Bristol Myers Squibb, where responsibilities encompassed brand management in immuno-oncology across the UK, Ireland, and Sweden, and a consulting role at Sirona Health Solutions focused on strategic services for healthcare providers. Johan's educational background includes degrees in Industrial Engineering and Management, as well as management and economics of innovation from esteemed institutions such as Chalmers University of Technology and ETH Zürich.
This person is not in the org chart
This person is not in any teams
This person is not in any offices